Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,748
Closed -$216K 50
2024
Q2
$216K Sell
1,748
-208
-11% -$26.8K 0.15% 45
2024
Q1
$258K Sell
1,956
-40
-2% -$4.93K 0.19% 39
2023
Q4
$218K Buy
+1,996
New +$207K 0.17% 43
2023
Q3
Sell
-1,994
Closed -$230K 48
2023
Q2
$230K Sell
1,994
-205
-9% -$23.3K 0.19% 41
2023
Q1
$234K Sell
2,199
-105
-5% -$11.3K 0.19% 40
2022
Q4
$256K Buy
+2,304
New +$236K 0.23% 36
2022
Q3
Sell
-2,290
Closed -$209K 49
2022
Q2
$209K Sell
2,290
-825
-26% -$73.1K 0.2% 45
2022
Q1
$256K Sell
3,115
-643
-17% -$50.7K 0.2% 59
2021
Q4
$288K Buy
+3,758
New +$299K 0.23% 71

Other funds holding MRK

Echo45 Advisors's MRK Position: Q3 2024 in Review

Echo45 Advisors sold out of Merck (MRK) in Q3 2024, closing a stake of 1,748 shares — an estimated $216K sold.

Echo45 Advisors first reported a position in MRK in Q4 2021 and held it in 9 quarters. The position peaked at $288K in Q4 2021. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Echo45 Advisors reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Echo45 Advisors sold 1,748 Merck shares in Q3 2024, an estimated $216K.
  • Echo45 Advisors first reported a position in Merck in Q4 2021 and held it in 9 quarters.
  • Echo45 Advisors's Merck position peaked at $288K in Q4 2021.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Echo45 Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.